1 The role of nitric oxide (NO) in ischaemia-reperfusion injury to the heart continues to be debated. 2 The role of NO released during endotoxemia on myocardial reperfusion injury was examined in rats given saline or lipopolysaccharide (LPS, 10 mg kg 71 ). 3 Aortic rings from LPS-treated rats showed a markedly decreased contractile response to both noradrenaline (NA) and U46619, and a diminished relaxation response to acetylcholine, thrombin and aggregating platelets. Treatment of rat aortic rings from LPS-treated rats with the NO synthesis inhibitor N o -nitro-L-arginine (L-NOARG) reversed the diminished contractile response to NE and U46619. 4 Before ischaemia-reperfusion, baseline force of cardiac contraction (FCC) and coronary perfusion pressure (CPP) were lower and coronary¯ow was higher in hearts from LPS-treated rats (all P50.05 vs. saline-treated group). Treatment of hearts from LPS-treated rats with L-NOARG increased baseline FCC and CPP. 5 After ischaemia-reperfusion, hearts from saline-treated rats showed a 36+5% fall in FCC, a 38+6% rise in CPP and a 38+5% fall in coronary¯ow, whereas hearts from LPS-treated rats revealed only a 16+9% fall in FCC, a 10+3% rise in CPP and a 20+4% fall in coronary¯ow (all P50.05 vs. changes in saline-treated group). Fewer hearts from LPS-treated rats developed reperfusion arrhythmias (6% vs. 60% hearts from saline-treated rats, P50.02). Myocardial superoxide dismutase activity was higher in the LPS-treated group (P50.05). 6 NO synthesis, measured as formation of nitrite, was higher (P50.05) in cardiac and aortic tissues from LPS-treated rats. Prostacyclin (PGI 2 ) release in coronary euent was greater in LPS-treated rat hearts (P50.05 vs. saline-treated rats). 7 Thus LPS-treated hearts demonstrate a basal decrease in FCC and coronary vascular resistance. These hearts demonstrate a modest protection from reperfusion injury. Induction of NO synthesis, and possibly PGI 2 release, may underlie cardioprotection from ischaemia-reperfusion.
Introduction
The basal release of small amounts of nitric oxide (NO) by a constitutive, Ca 2+ -dependent NO synthase in vascular endothelium plays an important role in the control of blood pressure and regional blood¯ow by stimulating the accumulation of guanosine 3' : 5'-cyclic monophosphate (cyclicGMP) in vascular smooth muscle cells (Furchgott & Vanhoutte, 1989; Moncada et al., 1991) . Reperfusion of previously ischaemic myocardial regions results in endothelial dysfunction, increase in coronary vascular resistance, and extension of myocardial injury (Mehta et al., 1989; McLenachan et al., 1990; Yang et al., 1993; Chen et al., 1995) . Much of this phenomenon of`reperfusion injury' has been attributed to inactivation or loss of release of NO and release of superoxide anions Chen et al., 1995) . Therefore, augmentation of synthesis, release or activity of NO during ischaemia-reperfusion should be bene®cial (Salvemini & Mollace, 1994) . However, the eects of NO on myocardial ischaemia/reperfusion injury have been controversial (Feigl, 1988; Beckman et al., 1990; Johnson et al., 1990; Matheis et al., 1992; Siegfried et al., 1992; Weyrich et al., 1992; Patel et al., 1993; Yang et al., 1993) . Lefer's group demonstrated that administration of NO precursor L-arginine (Weyrich et al., 1992) or NO donors, acidi®ed sodium nitrite or morpholino-sydnonimine 1 (SIN-1) (Siegfried et al., 1992) , mitigates against ischaemia-reperfusion-induced myocardial injury and endothelial dysfunction in anaesthetized cats. The salutary eects of L-arginine against myocardial ischaemiareperfusion injury have also been shown in rat isolated buerperfused hearts (Yang et al., 1993) . On the other hand, Beckman et al. (1990) have proposed that formation of peroxynitrite from superoxide anion and NO may be an important determinant of tissue injury following ischaemia-reperfusion. Matheis et al. (1992) showed that administration of an NO synthesis inhibitor N o -nitro-L-arginine methyl ester (L-NAME) protected against myocardial reoxygenation injury in pigs subjected to cardiopulmonary bypass. Patel et al. (1993) also showed that administration of L-NAME reduced infarct size following sustained coronary artery occlusion and reperfusion in rabbit hearts in situ. The protective eects of L-NAME against ischaemia have also been demonstrated in a rat cerebral ischaemia model by Buisson et al. (1992) .
There are two dierent isoforms of NO synthase, ®rst the constitutive isoform which catalyses formation of small amount of NO, the second inducible form which results in release of large amounts of NO and plays an important role in defending host against invading microorganisms (Furchgott & Vanhoutte, 1989; Moncada et al., 1991) . Cytotoxic eects of a large amount of NO have been shown in tumour cells, hepatocytes, and neural cells (Billiar et al., 1981; Stuehr & Nathan, 1989; Dawson et al., 1992) . NO release also has been shown to mediate negative inotropic eects of cytokines (Finkel et al., 1992; Balligand et al., 1993) and of bacterial products, such as lipopolysaccharide (LPS) (Brady et al., 1992) . It may be speculated that release of large amounts of NO either directly or by formation of large amounts of peroxynitrite, may be detrimental to myocardial tissues, particularly in states of ischaemia-reperfusion when tissues are at risk of free-radical-mediated injury (Thompson & Hess, 1986) . The present study, therefore, employed administration of LPS to rats to investigate the role of elevated NO level on myocardial ischaemia-reperfusion injury and vascular reactivity in a rat model.
Methods
These studies were approved by the University of Florida animal research committee, and all local, state and federal guidelines were followed in the conduct of the study.
Treatment of rats
Male Sprague-Dawley rats weighing 275 ± 300 g (heart weight 900 ± 1000 mg) were injected intraperitoneally with: (a) 0.55 ± 0.6 ml of saline (n=19), (b) LPS (from Escherichia coli, serotype 0127:BB) 10 mg kg 71 in saline (n=20).
Isolated perfused hearts
Six hours after the treatment, rats were anaesthetized with sodium pentobarbitone (50 mg kg 71 ) intraperitoneally. Blood was drawn from the common carotid artery into 3.8% sodium citrate (v:v=9 : 1) to harvest platelets. The hearts and aortae were rapidly excised and placed in ice-cold Krebs-Henseleit (K-H) buer composed of (mM): NaCl 118, KCl 4.7, KH 2 PO 4 1.2, MgSO 4 1.2, CaCl 2 2.5, NaHCO 3 25 and glucose 11. Within 1 min, the hearts were transferred to a perfusion apparatus and perfused via the aortas with oxygen-saturated (95% O 2 +5% CO 2 ) buer solution kept at 378C, pH 7.4, at constant perfusion¯ow (5.5 ± 6.0) by a MasterFlex pump (model 7016-21, Cole-Palmer Instrument Co., Chicago, IL) or constant perfusion pressure (80 cm H 2 O), according to the modi®ed Langendor procedure (retrograde, no-recirculation) (Neely & Rovetto, 1975; Yang et al., 1993) . The heart was placed in a semi-closed, circulating water warmed (378C) air chamber, paced at 300 beats min 71 with an atrial placing Medtronic 5320 (Medtronic, Inc., Minneapolis, MN) pacemaker. Coronary perfusion pressure (CPP, in constant¯ow hearts) was measured via a catheter placed just proximal to the aorta and connected to a Gould Statham P23ID pressure transducer (Hato Ray, Puerto Rico). To ascertain the changes in coronary resistance, some hearts were perfused at constant pressure. In constant pressure perfused hearts, coronary¯ow was also measured. To measure the force of cardiac contraction (FCC), the aorta was ®xed at 2 ± 3 mm above the root, a metal hook was connected to the apex of the heart, and connected to a force transducer (Kristler Morse, Redmond, WA) via a lever with the fulcrum at the middle, as described previously (Yang et al., 1993; Yang & Mehta, 1994a) . This technique measures FCC across the long-axis, and re¯ects changes in contractility in the intact heart. The myocardial preload during equilibration was kept at about 2 g. Both the CPP and FCC were continuously recorded on a four-channel recorder (AstroMed, West Warwick, RI). Heart rate was monitored from the fast speed tracing of the cardiac contraction signals.
Preparation of aortic rings
Rat thoracic aorta was placed in ice-cold K-H buer, cleaned of fat and loose connective tissues and cut into 4 to 5 mm rings. The rings were mounted onto wire stirrups, connected to Grass force-displacement transducers FT03 (Grass Instrument, Quincy, MA) and suspended in custom-designed tissueorgan baths ®lled with oxygen-saturated (95% O 2 +5% CO 2 ) Krebs-Ringer buer (composition in mM: NaCl 118, KCl 4.7, CaCl 2 2.5, KH 2 PO 4 1.2, MgCl 2 1.2, NaHCO 3 12.5, Na-EDTA 0.01 and glucose 11.1, pH 7.4). The rings were then stretched to and maintained at a preload of 5 g, and allowed to equilibrate for about 2 h. During equilibration, the buer was replaced every 30 min and continuously aerated with 95% O 2 +5% CO 2 , as described previously (Yang & Mehta, 1994b ).
Preparation of platelets
Anticoagulated blood was centrifuged at 100 g for 10 min at room temperature to obtain platelet-rich plasma (PRP). An aliquot of PRP (®nal platelet count 5610 8 cells ml
71
) was saved for aggregation in response to ADP (Yang & Mehta, 1994b) . The remaining PRP from saline-treated rats was centrifuged at 1000 g for 20 min at 48C. The pellet was washed twice with Tris-sodium-glucose (TSG) buer (composition in mM: Tris-HCl 15, NaCl 134, EDTA 1 and glucose 5, pH 7.4) and suspended in a ®nal platelet concentration of 10 9 cells min 71 in TSG buer. These washed platelets showed a normal aggregatory response to thrombin (1 u ml 71 ) (Yang & Mehta, 1994b) . Platelets were separated from PRP about 30 min before being suspended in the organ baths. During this period, washed platelets were kept on ice. These platelets were used to examine vasorelaxation.
Experimental protocols
Ischaemia-reperfusion Four hearts from saline-treated rats were continuously perfused with K-H buer at constant¯ow (5.5 ± 6.0 ml min 71 ) for 90 min and served as sham controls. Other hearts (10 from saline-treated rats and 10 from LPStreated rats) were equilibrated for 20 min under continuous ow, then subjected to 40 min of total ischaemia (stop perfusion) followed by 30 min of reperfusion. FCC and CPP were continuously recorded. Coronary euent was collected several times during the experiment and stored at 7708C for measuring 6-keto-prostaglandin F 1a (6-keto-PGF 1a ), the stable metabolite of PGI 2 . After the experiment, hearts were sealed and stored at 7708C for measuring myocardial creatine kinase (CK), superoxide dismutase (SOD) and malondialdehyde (MDA).
Five hearts from saline-treated rats and 6 hearts from LPStreated rats were perfused at constant pressure (80 cmH 2 O), stabilized for 20 min, then subjected to 40 min of ischaemia and 30 min of reperfusion. FCC and coronary¯ow were continuously recorded. Four hearts from LPS-treated rats were perfused with K-H buer containing the NO synthesis
perfused at constant¯ow and then subjected to 40 min of ischaemia and 30 min of reperfusion.
Aortic ring reactivity Parallel sets of aortic rings were exposed to cumulative concentrations of noradrenaline free base (NA, 0.1 nM ± 10 mM) or the thromboxane (TX) A 2 analogue U46619 (10 fM ± 1 nM) to determine the vascular contractile response. Some rings from LPS-treated rats were incubated with L-NOARG (500 mM) for 5 ± 10 min, and then exposed to NA or U46619. Other parallel sets of aortic rings were contracted with NA to obtain &2 ± 3 g of tone (&70 ± 80% of maximal tone), then exposed to acetylcholine chloride (ACh, 0.1 nM ± 10 mM), thrombin (0.1 ± 1.0 u ml 71 ) or washed autologous platelets (10 6 ± 10 8 cells ml 71 ) so as to determine the vasorelaxant response. Since platelets cause relaxation of arteries with intact endothelium and cause contraction of arteries without functional intact endothelium (Yang & Mehta, 1994c) , platelets were suspended in the organ bath to not only test endothelium-dependent vasorelaxation, but also to examine endothelial integrity. After each experiment, aortic rings were weighed for calculation of vasoconstriction in g (tone) mg 71 (tissue).
Determination of NO synthase activity in myocardial and aortic tissues NO synthase activity was determined by measuring nitrite formation in myocardial homogenates or aortic tissues. In brief, hearts and aortae from saline-treated and LPS-treated rats were washed with K-H buer. Hearts were homogenized in Ca 2+ -rich buer, and the homogenate and aortic segments were then incubated with L-arginine (5 mM) for 1 h. Aortic segments were then homogenized. The homogenates were centrifuged at 3000 g for 30 min at 48C. Protein in the myocardial supernatant was measured according to the method of Lowry et al. (1951) . Nitrite in the myocardial and aortic supernatants was measured by the Griess reaction (Green et al., 1982) . Nitrite in myocardial supernatant was expressed as nmol mg 71 protein. Nitrite in aortic supernatant was expressed as nmol mm 71 length of the vessel.
Myocardial SOD and MDA measurements
Myocardium was homogenized in 5% distilled water. Aliquots of homogenate were centrifuged at 5000 g for 60 min at 48C. The superoxide dismutase (SOD) activity in the supernatant was measured by spectrophotometric monitoring of the SOD inhibitable autooxidation of pyrogallol as described by Marklund and Marklund (1974) . One unit of SOD was de®ned as inhibition of autooxidation of pyrogallol by 50%. Malondialdehyde (MDA) content of the myocardial homogenate was measured by thiobarbituric acid method (Ohkawa et al., 1979) . Protein in the myocardial supernatant was measured according to the method of Lowry et al. (1951) .
6-keto-PGF 1a assay
Prostacyclin release was measured by quantitation of its stable hydrolysis product 6-keto-PGF 1a in the coronary euent by enzyme-linked immunosorbent assay (ELISA) (Folger et al., 1991) .
Reagents LPS (derived from Escherichia coli, serotype 0127:B8), L-NOARG, NA and other reagents were obtained from Sigma Chemical Co., St. Louis, MO. U46619 ((5Z, 9a,13E, 15S)-11,9-(E.poxymethano) prosta-5, 13-dien-1-oic acid) was a gift from Pharmacia-Upjohn, Kalamazoo, MI. All reagents were fresh made before use.
Statistical analysis
All data are expressed as mean+s.e.mean. One-way or twoway analysis of variance (ANOVA) followed by Student Newman-Keul's test or Chi-Square was used to evaluate the statistical signi®cance of data. A P value less than 0.05 was considered signi®cant.
Results
Six hours after intraperitoneal administration, rats in the saline group showed no evidence of distress, but rats given LPS appeared lethargic. However, none of the rats died during the 6 h of observation.
Platelet counts and aggregation
In the saline-treated rats, the platelet count in the peripheral blood was 4.5+1.1610 9 cells ml 71 and the magnitude of ADP-induced platelet aggregation was 62+3%. In the LPStreated rats, both platelet count and platelet aggregation were signi®cantly lower (1.3+0.71610 9 cells ml 71 and 30+2%, respectively, both P50.01 vs. saline-treated rats). 
Vascular reactivity
As shown in Figure 1 , the contraction of aortic rings in response to both NA and U46619 was signi®cantly diminished in the LPS-treated group compared to the salinetreated group (P50.01). Treatment of aortic rings from LPS-treated rats with L-NOARG restored the contractile response to NA as well as U46619, and the contractile response in the case of NA became somewhat greater than that in saline-treated rats.
The relaxation in response to ACh, thrombin, and platelets was also markedly decreased in rings from LPS-treated rats compared with that in rings from saline-treated rats (P50.01) (Figure 2 ). There was no contractile response on addition of platelets. Treatment of rings from LPS-treated rats with L-NOARG abolished the relaxation in response to ACh and thrombin (Figure 2 ).
Cardiac dynamics during equilibration, ischaemia and reperfusion
In the continuously perfused hearts from saline-treated rats, there were nonsigni®cant changes in CPP and FCC during a 90 min period of observation.
In the LPS-treated group (constant¯ow perfused hearts), both CPP and FCC were lower at the beginning of perfusion (CPP: 43+1 vs. 48+1 mmHg; FCC: 6.6+0.4 vs. 9.8+0.7 in the saline-treated group, both P50.05). Total ischaemia (40 min) followed by reperfusion (30 min) resulted in a marked decrease in FCC and increase in CPP in all hearts (Figure 3) . The magnitudes of the decrease in FCC and increase in CPP were less marked in hearts from LPStreated than those from saline-treated rats (P50.01) ( Figure  3) .
In hearts perfused with a constant pressure, coronary¯ow was higher (8.1+0.5 vs. 7.1+0.5 ml min 71 ) and FCC was lower (7.0+1.0 vs. 10.0+0.5 g) in the LPS-treated group than in the saline-treated group at the beginning of perfusion (both P50.01 vs. saline-treated group). Total ischaemia followed by reperfusion resulted in a decrease in FCC and coronary¯ow in both saline-and LPS-treated groups; however, the magnitude of the decrease was less marked in the LPS-treated group (P50.05) (Figure 3) .
The frequency of transient ventricular ®brillation in hearts from the saline-treated group during reperfusion was 60% (9 of 15 hearts). In contrast, only 6% of the hearts from the LPS-treated group (1 of 16 hearts) showed transient ventricular ®brillation (P50.01 vs. saline-treated group).
Treatment of hearts from LPS-treated rats with L-NOARG (n=4) resulted in marked increase in FCC (+51%) and CPP (+113%) during 20 min of equilibration. The FCC and CPP did not stabilize for 40 min and these hearts were not subjected to ischaemia-reperfusion.
Indices of oxidant activity
Myocardial SOD activity was lower in the saline-treated group (P50.05 vs. sham control hearts) and was preserved in the LPS-treated group after ischaemia/reperfusion. Myocardial MDA content was higher in saline-treated hearts subjected to ischaemia-reperfusion than in sham control hearts (P50.05). However, treatment with LPS did not aect the ischaemia/ reperfusion elevated MDA content of the hearts (NS vs. salinetreated hearts) (Figure 4) . 
Coronary euent 6-keto-PGF 1a
As shown in Figure 5 , coronary euent 6-keto-PGF 1a concentrations during the entire experiment were signi®cantly higher in the LPS-treated group than in the saline-treated group (P50.01).
Myocardial and aortic NO synthase activity
Nitrite concentration in the supernates of myocardial homogenates was 3.4+0.1 in the saline-treated group and 4.9+0.1 nmol mg 71 protein in the LPS-treated group. The dierence between these means was signi®cant (P50.05). Similarly, nitrite concentrations in aortic ring supernates were higher in the LPS-treated rats (mean 2.1+0.3 vs. 1.4+0.2 nmol mm 71 segment in saline-treated group, P50.05).
Discussion
In this study, rats treated with LPS showed clear evidence of endotoxaemia, as re¯ected by a decrease in platelet number and platelet aggregation. In addition, there was suppression of the contractile response of aortic rings to both NA and U46619 and a decrease in the relaxant response to various endothelium-dependent vasodilators. Furthermore, isolated hearts from LPS-treated rats showed diminished coronary vascular resistance and FCC compared to the hearts from saline-treated rats. These changes in the LPS-treated rats were associated with a signi®cant rise in NO synthase activity in myocardial and aortic tissues. LPS administration was also associated with increased PGI 2 release in the coronary euents. Treatment of hearts and aortae from LPS-treated rats with the NO synthase inhibitor L-NOARG in vitro reversed the LPS-induced cardiovascular depression. Taken together, these data indicate that treatment of rats with a single large dose of LPS results in the release of a large amount of NO and haemodynamic alterations. Schulz et al. (1992) have provided conclusive evidence of induction of NO synthase by LPS and cytokines in myocardium. Release of large amounts of NO would be expected to result in systemic hypotension (Schulz et al., 1992; Szalzo et al., 1993) . The vascular smooth muscle may become hyporesponsive to several pressor agents, including catecholamines (Wakabayashi et al., 1987; Szalzo et al., 1993) . In accordance with these concepts, we found a low coronary vascular resistance and suppressed contractile response of aortic rings from LPS-treated rats to two dierent stimuli, NA and U46619. The reduced responsiveness of aortic rings to vasoconstrictor stimuli was`normalized' and coronary vascular resistance in the isolated hearts was increased following pretreatment with the NO synthesis inhibitor L-NOARG. We also found diminished relaxation of aortic rings from LPS-treated rats in response to three dierent endothelium-dependent vasorelaxants, ACh, thrombin and platelets. Whereas the phenomenon of diminished vasoconstriction can be attributed to release of large amounts of NO in the aortic tissues from LPS-treated rats, diminished endothelium-dependent relaxation may also be due to the inhibitory eect of endotoxin on Ca
2+
-dependent constitutive NO synthase activity (Parker & Adams, 1993; Graier et al., 1994) . Of note is the fact that suspension of platelets caused relaxation of aortic rings from LPS-treated rats albeit less than in saline-treated rats, which indicates that the vascular endothelium after LPS-treatment remained intact.
FCC was markedly reduced in hearts from LPS-treated rats, probably a re¯ection of the negative inotropic eect of LPS (Brady et al., 1992) . Adams et al. (1990) found intrinsic myocardial dysfunction during endotoxaemia-independent of changes in coronary¯ow. In support of a role for LPS-induced NO release in diminished FCC is our observation of normalization' of FCC in hearts from LPS-treated rats by L-NOARG treatment.
The eects of NO on myocardial dysfunction induced by ischaemia and reperfusion have been controversial. Whereas early studies suggested a salutary eect of NO on myocardial function following reperfusion injury Siegfried et al., 1992; Weyrich et al., 1992) , more recent studies have shown a protective eect of NO inhibitors in the intact animal (Buisson et al., 1992; Matheis et al., 1992; Patel 1993) . However, all these studies Buisson et al., 1992; Matheis et al., 1992; Siegfried et al., 1992; Weyrich et al., 1992; Patel et al., 1993) presumed the NO release was altered during ischaemia-reperfusion, and did not dierentiate between constitutive and inducible NO release.
The present study was speci®cally designed to address the issue of LPS and ischaemia-reperfusion-induced myocardial dysfunction. We found that treatment of rats with LPS attenuated the deterioration of myocardial function in response to ischaemia-reperfusion. Reduction in the frequency of transient ventricular arrhythmias during the reperfusion phase in LPStreated hearts also suggests some cardioprotection.
Protection against reperfusion-mediated myocardial dysfunction by LPS administration in the present study may relate to several mechanisms. Firstly, the release of oxygen free radicals during early stages of reperfusion contributes to myocardial injury (Thompson & Hess, 1986 ) and endothelial dysfunction (Mehta et al., 1989; McLenachan et al., 1990; Tsao et al., 1990; Yang et al., 1993) , mediated at least in part by inactivation of NO. Release of large amounts of NO following LPS administration may have counteracted the detrimental eects of free radicals on the myocardium and coronary vasculature. Secondly, direct inhibition of the generation of superoxide anions by NO (Clancy et al., 1992) may be a mechanism for the cardioprotective eects of LPS. Thirdly, release of PGI 2 in coronary euent of hearts from LPS-treated group may have contributed to the cardioprotective eects of LPS (Lefer & Arak, 1980) . The increase in PGI 2 release could be a direct response to endotoxin administration (Wise et al., 1980) . PGI 2 has also been shown to reduce the generation of superoxide anions (Fantone & Kinnes, 1983) . Lastly, a decrease in FCC and resistance in the coronary microvasculature in response to NO and PGI 2 may reduce wall stress and oxygen demand and result in a reduction in reperfusion injury.
The ability of LPS to trigger the release of a number of other mediators apart from NO and PGI 2 needs to be recognized, such as cytokines, endothelin, arachidonic acid metabolites, complement factors, bradykinin, histamine, 5-hydroxytryptamine, catecholamines and shock proteins. Many of these mediators could also participate in the determination of cardiac function following reperfusion unrelated to the alterations in NO. In the present study, we only demonstrated the increased release of NO and PGI 2 in the isolated preparation, which may well have been salutary to the heart during ischaemia reperfusion. Since the myocardial ischaemia reperfusion was performed in vitro, the LPS-induced release of factors other than NO and PGI 2 should be much less than that in vivo. Most of these LPS-released mediators (other than NO and PGI 2 ) exert cytotoxic and vasoconstrictor eects, and may not be expected to exert bene®cial eects during ischaemiareperfusion. We postulate that the LPS-induced NO and PGI 2 release probably contributes to the observed bene®cial eect of LPS-treatment on the isolated heart following ischaemia-reperfusion.
To ascertain the role of NO release, we planned to inhibit the NO synthesis by perfusion of hearts with L-NOARG, but were not able to subject the hearts to ischaemia-reperfusion due to the lack of stabilization of the cardiac preparations. We also examined the eect of in vivo administration of L-NAME (an inhibitor of NO synthesis) 30 min before LPS on the LPSmediated cardiac eect in vitro in some rats. In data not presented here, we found a detrimental eect of the administration of combination of L-NAME and LPS on cardiac and systemic haemodynamics resulting in high mortality, similar to data found by Wright et al. (1992) . In the isolated hearts from surviving rats, we found no dierence in the cardiac performance between the hearts from LPS-treated rats and the hearts from L-NAME+LPS-treated rats. The eect of NO inhibition is thus not clear from these studies; therefore, we did not present these data in the present manuscript. Notably, administration of dexamethasone, which prevents the activity of inducible NO synthase as well as the detrimental eect of other mediators of endotoxic shock, was not found to protect against the haemodynamic eects of LPS (Wright et al., 1992) . Thus the nature of the speci®c mediator released in response to LPS administration, which exerts a cardioprotective eect, remains unclear.
In the present study, myocardial SOD activity after ischaemia and reperfusion was higher in LPS-treated rats than in the saline-treated rats, which is consistent with the concept of NO and PGI 2 reducing the generation of superoxide anions (Fantone & Kinnes, 1983; Clancy et al., 1992) . NO can also combine with superoxide radicals in vitro to produce the potentially cytotoxic substance peroxynitrite (Beckman et al., 1990) . This radical has been shown to oxidize sulphydryl groups and peroxidize membrane lipids (Radi et al., 1991) . Pearson et al. (1991) have indicated that hypoxia enhances the production of an endothelium-derived constricting factor which they propose to be peroxynitrite. Therefore, it is possible that peroxynitrite is produced during ischaemia-reperfusion injury; however, to date the production of peroxynitrite has only been demonstrated in vitro. Additionally, due to the short life-time (1.9 s) (Beckman et al., 1990 ) and the high concentration of peroxynitrite required to produce lipid peroxidation (100 mM to 1 mM) (Radi et al., 1991) , it is unlikely that peroxynitrite plays a signi®cant role in ischaemia-reperfusionmediated injury.
Conclusion
In summary, administration of LPS results in release of NO and PGI 2 . The net eect of these mediators is a decrease in coronary vascular resistance and FCC. The hearts from LPStreated rats appear to be somewhat protected from the detrimental eects of ischaemia-reperfusion. It is likely that release of large amounts of NO, and possibly PGI 2 , is responsible for cardioprotection. However, some other mediator released in response to LPS administration may also exert a cardioprotective eect following ischaemia-reperfusion.
